helicobacter pylori: biochemical mechanism of mucosal injury

Reading File

Finding Sources

Searching PubMed

"Helicobacter pylori" AND "mucosal injury" AND mechanism

Reading File

Loading Image

Reading File

I now have comprehensive information from multiple authoritative sources. Let me compile the full answer.

Helicobacter pylori: Biochemical Mechanisms of Mucosal Injury

H. pylori causes mucosal injury through a coordinated set of mechanisms that can be grouped into: (1) colonization strategies, (2) direct toxin/enzyme effects, (3) immune-mediated injury, and (4) disruption of acid homeostasis.

1. Colonization and Initial Survival

Before any injury can occur, H. pylori must survive the hostile gastric environment. It does this via two critical adaptations:

Urease - Up to 15% of the organism's total protein is cytoplasmic urease. It converts periplasmic urea into CO₂ and ammonia (NH₃), which buffers the surrounding acid micro-environment. This local alkalinization lets the bacteria survive the gastric lumen long enough to burrow into the mucus layer. Strains lacking urease are nonpathogenic.

Flagella - Specialized flagella propel the organism from the gastric lumen, across the mucus gel, to the surface epithelium. Flagella-deficient strains are likewise nonpathogenic.

H. pylori resides predominantly in the deeper portions of the mucous gel or at the interface between the mucous layer and gastric epithelium. It typically does not invade the epithelial cell layer itself. - Harrison's Principles of Internal Medicine 22E, p. 2563

2. Adhesion and Direct Epithelial Injury

Once embedded near the epithelium, H. pylori attaches to gastric epithelial cells via specific adhesins:

Neutrophil-activating protein A (NapA)
Heat shock protein 60 (HspB)
Sialic acid-binding adhesin (SabA)
Outer membrane proteins (Hop proteins)

Attachment triggers direct injury and initiates the host inflammatory response. - Schwartz's Principles of Surgery 11E, p. 1145

3. Virulence Toxins - The Core Injury Mediators

Vacuolating Cytotoxin A (VacA)

VacA is secreted by most H. pylori strains and causes vacuolation within epithelial cells by forming anion-selective channels in the plasma membrane. This disrupts intracellular vesicular trafficking, induces mitochondrial apoptosis, and damages the epithelial barrier. The degree of vacuolation correlates with tissue damage. - Harrison's 22E

CagA (Cytotoxin-Associated Gene A) - the Major Oncogenic Virulence Factor

The cag pathogenicity island (cag-PAI) encodes a type IV secretion system that injects the CagA protein directly into host gastric epithelial cells. Once inside:

CagA activates a cascade of cellular events controlling cell proliferation, cytokine production, and cytoskeletal rearrangement
It disrupts normal cell polarity and tight junctions
It promotes inflammatory signaling, contributing to gastritis and increasing carcinogenic risk

CagA-positive strains are significantly more associated with peptic ulceration and gastric cancer than CagA-negative strains. - Harrison's 22E, p. 2563; Bailey & Love 28E, p. 1176

4. Enzymatic Disruption of the Mucus Barrier

Beyond urease, H. pylori produces several enzymes that directly degrade mucosal defenses:

Enzyme/Factor	Effect
Urease	Produces NH₃ - toxic to epithelium at high concentrations; disrupts mucus gel structure
Lipase	Degrades phospholipids in the mucus layer and cell membranes, reducing surface hydrophobicity
Catalase	Neutralizes host hydrogen peroxide (H₂O₂), helping evade oxidative killing
Platelet-activating factor (PAF)	Promotes local inflammation and vascular injury
PicB	Induces cytokine production in host cells

The net result is disruption of the gastric mucous barrier, reducing the gel's protective properties and allowing luminal acid and pepsin to access the underlying epithelium. - Harrison's 22E; Bailey & Love 28E

5. Immune-Mediated Mucosal Injury

H. pylori does not simply destroy tissue by direct toxicity - the host immune response is a major driver of injury:

Acute phase: Recruitment of neutrophils is the initial inflammatory response. Neutrophils release reactive oxygen species (ROS) and reactive nitrogen species (RNS) that cause oxidative epithelial damage.

Chronic phase: Sequential accumulation of T and B lymphocytes, plasma cells, and macrophages follows. The resultant chronic gastric inflammation is characterized by:

Enhanced mucosal expression of proinflammatory cytokines - IL-8, TNF-α, IL-1β
Persistent generation of ROS and RNS
Mucosal cell DNA damage and chromosomal instability
Increased apoptosis

This immune-mediated injury progressively weakens mucosal defenses. Notably, H. pylori has evolved mechanisms to avoid complete destruction by the mucosal immune system, enabling it to persist for decades. - Schwartz's 11E, p. 1145

6. Gastric Acid Dysregulation - The Somatostatin-Gastrin Axis

This is the mechanism linking H. pylori to duodenal ulcer specifically:

Step-by-step sequence:

Ammonia from urease alkalinizes the antrum - normally, luminal acid stimulates D cells to release somatostatin, which inhibits gastrin from G cells. Ammonia blunts this feedback.
Depletion of antral somatostatin (D cells) - via three proposed mechanisms:
- Direct antral alkalinization removes the acid stimulus for somatostatin release
- Toxic cytokine effect on D cells
- H. pylori produces N-α-methylhistamine, an H₃ receptor agonist that binds H₃ receptors on D cells, directly suppressing somatostatin release
Unopposed G cell (gastrin) activity → hypergastrinaemia
Gastrin stimulates ECL cells → increased histamine release → parietal cell stimulation → acid hypersecretion and parietal cell hyperplasia
High duodenal acid load causes gastric metaplasia of the duodenum (a protective response)
Gastric metaplastic patches in the duodenum can now be colonized by H. pylori (normal duodenal mucosa cannot be infected). This produces local duodenitis and ultimately duodenal ulceration. The risk of duodenal ulcer increases 50-fold in patients with gastric metaplasia of the duodenum.

Additionally, H. pylori colonization of the duodenum causes a significant decrease in acid-stimulated duodenal bicarbonate production, removing a key mucosal defense against luminal acid.

In contrast, with long-standing infection involving the corpus (body), H. pylori can inhibit H⁺-K⁺-ATPase expression, leading to hypochlorhydria and atrophic gastritis - the pathway toward gastric cancer. - Schwartz's 11E, p. 1146; Harrison's 22E, p. 2564

Diagram showing gastric acid regulation: the G cell/D cell/ECL cell/parietal cell axis with gastrin, somatostatin, histamine, and acetylcholine pathways

Normal gastric acid regulation - H. pylori disrupts this axis primarily by suppressing somatostatin and driving hypergastrinaemia (Harrison's 22E)

7. Histological Appearance of Mucosal Injury

Histology: antral mucosa colonized by H. pylori (modified Giemsa stain), showing the rod-shaped organisms at the epithelial surface amid inflammatory infiltrate

Antral mucosa showing H. pylori colonization with inflammatory cell infiltration (modified Giemsa stain) - Bailey & Love 28E, p. 1176

Outcome Depends on Distribution of Gastritis

Gastritis Pattern	Predominant Pathology
Antral-predominant (most common in the West)	Hypergastrinaemia, acid hypersecretion → duodenal ulcer
Corpus/pangastritis (more common in developing world)	Acid suppression, atrophy, intestinal metaplasia → gastric ulcer, gastric adenocarcinoma, MALT lymphoma

Summary of Key Biochemical Events

H. pylori colonizes mucus layer
       ↓
Urease → NH₃ (local buffering + epithelial toxicity + antral alkalinization)
       ↓
Flagellar motility → epithelial adhesion (Hop proteins, NapA, HspB, SabA)
       ↓
Lipase + Urease → mucous barrier degradation
       ↓
VacA toxin → epithelial vacuolation → apoptosis
CagA (type IV SS) → intracellular signaling → cytokine production, DNA damage
       ↓
Neutrophil recruitment → ROS/RNS → oxidative epithelial damage
Macrophage/lymphocyte accumulation → IL-8, TNF-α, IL-1β → chronic inflammation
       ↓
Antral D cell suppression → ↓somatostatin → ↑gastrin → ↑acid
                                                       ↓
                                    Duodenal gastric metaplasia → H. pylori colonization
                                    → duodenal ulcer

Sources: Schwartz's Principles of Surgery 11E, pp. 1145-1146 | Harrison's Principles of Internal Medicine 22E, pp. 2563-2564 | Bailey & Love's Short Practice of Surgery 28E, pp. 1176-1177 | Medical Microbiology 9E

This is a shared conversation. Sign in to Orris to start your own chat.